Biostem Technologies Completes Test-O-Shave Product Line Acquisition

11 Dec, 2015, 09:30 ET from Biostem Technologies, Inc.

OAKLAND PARK, Fla., Dec. 11, 2015 /PRNewswire/ -- (OTC: BSEM), Biostem Technologies, Inc. is pleased to announce the acquisition of another product line. Biostem Technologies (BSEM) acquired this asset by virtue of a stock exchange valued at, $155,500. Test-O-Shave is a product line focusing on providing natural grooming and hygiene products. In addition to the men's line of products, Test-O-Shave produces organic soaps, creams, oils, and a women's shave line in development. What sets this product line apart is its natural testosterone boosting ingredients, Pine Pollen and Tribulus.1 It has been shown that bisphenol A (PBA), preservatives and other artificial ingredients can naturally decrease your testosterone levels.1 Therefore; Test-O-Shave, with it's all natural Pine Pollen and Tribulus may increase your natural testosterone levels.1 The Company will immediately re-brand this product line to its Bioshave brand to become the foundation of the Company's retail natural grooming and hygiene products.  

Dr. Bryan Schuetz D.C., who developed Test-O-Shave stated: "Commercially available shave soaps contain chemicals that may cause cancer and reduce normal testosterone levels. After learning of this I decided to form Test-O-Shave, a company that would produce only healthy, chemical free products for men and women to use each day. The first of these products is Test-O-Shave. After using this all natural formula for just a few days you will feel the difference from those old chemical shave creams that are just plain unhealthy for you. Get ready to feel what a real, natural product can do for you."

Jason Matuszewski, CEO of Biostem Technologies, commented: "We have continued to focus on identifying acquisitions as a means to grow and expand our capabilities, product offering and customer base. This last quarter, the company also decided to focus its resources in the upcoming year to penetrate the $5.4 billion cosmeceutical industry."

"The acquisition of the Test-O-Shave product line, provides us with a jump-start into this market. It is our goal to complete the re-branding of Test-O-Shave to our Bioshave line and launch our consumer marketing program by the end of the first quarter of 2016."

With a successful product launch following the brand conversion, management anticipates this acquisition will account for an increase in revenues for Biostem Wellness in excess of 30%

For more information about Test-O-Shave's natural grooming and hygiene products please visit www.bioshaveshop.com

1: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

About Biostem Technologies, Inc. (BSEM):

BioStem Technologies (BSEM) is engaged in the advancement of regenerative medicine and antiaging strategies throughout the United States, Europe and Mexico. BSEM's goal is to deliver the highest standard wellness and stem cell products that are backed by science. Through scientific studies, we seek to become a world leader in the wellness arena. This will be accomplished by using high quality nutraceuticals, cosmeceuticals, and stem cells. Our state of the art laboratory is the first significant step in our quest to introduce the world and our shareholders our dedication to you and your well-being. 

Forward-Looking Statements Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," "believe" or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and additional risks factors as discussed in reports filed by the company with OTC Markets.

 

SOURCE Biostem Technologies, Inc.